Drug Combination Details
General Information of the Combination (ID: C68816) | |||||
---|---|---|---|---|---|
Name | Alpha linolenic acid NP Info | + | Gentamicin Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Healthy individual
[ICD-11: N.A.]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Decreasing Adverse Drug Reaction by This Combination | ||||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
Up-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | CASP3 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | COX-2 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | NOS2 | Molecule Info |
Pathway MAP
|
||
In-vivo Model | Eight-week-old balb/c albino male mice were used in this study. | |||||
Experimental
Result(s) |
The gentamicin administration causes nephrotoxicity and the use of alpha-linolenic acid can be helpful against this toxic effect. |
References | ||||
---|---|---|---|---|
Reference 1 | Protective effect of alpha-linolenic acid on gentamicin-induced ototoxicity in mice. Somatosens Mot Res. 2017 Sep;34(3):145-150. |




